Insulin glargine

This classification denotes a therapeutic insulin with the molecular formula C267H404N72O78S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2ZM8CX04RZ, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG. The term INSULIN GLARGINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 11, No. 3 1997, List 38) WHO schedules insulin in its Anatomical Therapeutic Chemical (ATC) Classification. INSULIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule Insulin glargine under HS 29371900 and SITC 54154. SMILES:. As of Q4 2014, INSULIN GLARGINE remains US FDA's Preferred Term for this commodity. . Insulin glargine bears US NLM identifiers UMLS ID C0907402 and NCI Concept Code C47564.